Evidence map›Paper›PMID 38226061›Full record

ArticleERJ open research2024

Prescribing preferences and availability of nebulisers and inhalers for inhaled medications in bronchiectasis: results of a specialist survey.

Michal Shteinberg, Arietta Spinou, Pieter Goeminne, Megan Crichton, Charles Haworth, James D Chalmers

Open access · goldAbstract read
In one paragraph

Article in ERJ open research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Epidemiology of bronchiectasis.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  4. Patient-managed interventions for adults with bronchiectasis: evidence, challenges and prospects.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

Michal ShteinbergPulmonology Institute and CF Center, Carmel Medical Center, Haifa, Israel.ORCID https://orcid.org/0000-0002-0432-3398
Arietta SpinouSchool of Life Course and Population Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.ORCID https://orcid.org/0000-0002-3442-4739
Pieter GoeminneDepartment of Respiratory Diseases, AZ Nikolaas, Sint-Niklaas, Belgium.
Megan CrichtonDivision of Molecular and Clinical Medicine, University of Dundee, Dundee, UK.
Charles HaworthCambridge Centre for Lung Infection, Royal Papworth Hospital and University of Cambridge, Cambridge, UK.
James D ChalmersDivision of Molecular and Clinical Medicine, University of Dundee, Dundee, UK.
University of Dundee · GBKing's College London · GBTechnion – Israel Institute of Technology · ILUniversity of Cambridge · GBVlaamse Vereniging voor Obstetrie en Gynaecolo · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38226061
PMCPMC10789251
OpenAlexW4388721378

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.